Endocrinology coverage from diabetes to thyroid to bone health.
Diabetes therapeutics, CGM, thyroid imaging, osteoporosis biologics, and bone density diagnostics.
Endocrinology dynamics.
Endocrinology is concentrated in a small physician universe (~7K endocrinologists in the US) but with high per-physician influence — these are the specialists primary care defers to on complex diabetes, thyroid disease, osteoporosis, and pituitary disorders. Diabetes dominates the sales motion, with GLP-1s, insulin, and CGM creating a fast-moving therapeutic landscape. Each subspecialty (diabetes, thyroid, bone, pituitary, reproductive) has its own evidence base.
Why this specialty fits Solara reps.
Solara endocrinology reps carry portfolios that align with the diabetes-dominant economics of the specialty — therapeutics alongside CGM and adjacent diagnostics. Per-physician influence is high, and durable relationships compound across product introductions.
Apply to the networkWhat Solara delivers for endocrinology launches.
Manufacturers launching into endocrinology need rep coverage at the high-volume diabetes specialists and integrated endocrine groups. Solara's network provides that focus with adoption telemetry at the physician and practice level.
Book a working sessionWhat Endocrinology reps see most.
- ·Type 2 diabetes mellitus
- ·Type 1 diabetes mellitus
- ·Obesity / metabolic disease
- ·Thyroid disorders (hyper/hypothyroidism, thyroid cancer)
- ·Osteoporosis
- ·Hyperparathyroidism
- ·Adrenal insufficiency
Procedures that anchor the buying motion.
- 95251CGM interpretation and report
- 77080DXA bone density scan
- 76536Thyroid ultrasound
- 60100FNA of thyroid
- 99214Office E/M, established patient, level 4
Product categories most relevant to endocrinology.
Common questions about endocrinology on Solara.
- Does Solara cover diabetes specialists for GLP-1 and CGM launches?
Yes. Diabetes is the dominant sales motion in endocrinology, and the network covers GLP-1 launches, CGM technology, insulin innovations, and diabetes diagnostics with appropriate payer-aware messaging and patient-support workflow.
- Can Solara support thyroid and bone health subspecialty products?
Yes. Thyroid (imaging, ablation, oncology) and bone health (DXA, biologics for osteoporosis) are separate subspecialty workflows within the network. Reps are matched to physicians who actively practice in those areas.
- How does Solara handle the payer complexity of endocrinology products?
Reps are trained on payer step-therapy for GLP-1s, CGM coverage criteria, biologic prior-authorization for osteoporosis, and the patient-support resources manufacturers provide. Payer context is built into the script library.
- What targeting data is used for endocrinology?
Diabetes patient volume where reportable, prescribing patterns for diabetes therapeutics, CGM use density, payer mix, and subspecialty practice patterns. ICP scoring surfaces the endocrinologists with the right patient mix for the specific product.
See your endocrinology territory.
Drop in your metro on the territory preview tool — we'll surface the top 50 physicians most likely to adopt your product, scored on five signals.